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Alternanthera tenella Colla extracts are used in Brazilian traditional folk medicine to treat a variety of infectious 
diseases as well as inflammation and fever. In this work, the immunomodulatory, anti-inflammatory and potential 
toxic effects of cold (CAE) and hot (HAE) aqueous extracts of A. tenella were investigated in vivo. In addition, we an-
alyzed the phytochemical properties of both extracts. BALB/c mice were immunized in vivo with sheep red blood cells 
and concomitantly inoculated intraperitoneally (i.p.) with each extract (50, 100 or 200 mg/kg). Specific antibody-
producing cells were enumerated using plaque-forming cell assays (PFC) and anti-SRBC IgG and IgM serum levels 
were measured via enzyme-linked immunosorbent assay. Body and lymphoid organ weights were determined after 
treatments in order to evaluate toxic effects. Carrageenan-induced paw edema was employed to investigate anti-
inflammatory activity in mice inoculated i.p. with CAE or HAE (200 or 400 mg/kg). Phytochemical screening was 
performed using spectrometric and chromatographic approaches and revealed that CAE possessed higher tannin 
and flavonoid levels than HAE. PFC numbers were increased after treatment with CAE (100 mg/kg) four days after 
immunization, as were the serum antibody titers after four and seven days, suggesting immunostimulatory activity 
through modulation of B lymphocyte functions. Body and organ weights did not show major changes, suggesting that 
extracts administered to mice did not induce significant toxicity. Both extracts had significant anti-inflammatory 
activity in the paw edema assay. These results suggested that aqueous extracts from A. tenella contained several 
chemical compounds that possess positive and/or negative modulator effects on the immune system, which appeared 
to correlate with tannin and flavonoid levels in those extracts. In summary, these studies provide important insight 
into the biological activities of A. tenella.
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Utilization of natural products with therapeutic prop-
erties is as old as human civilization. For a long period 
of time, minerals, plants and animal products were the 
main sources of drugs with different properties (De 
Pasquale 1984). Today, many natural plant products and 
synthetic compounds have been evaluated for their ca-
pacity to modulate immune responses (Davis & Kuttan 
2000, Bin-Hafeez et al. 2003, Barnes et al. 2005, Cheng 
et al. 2005, Patwardhan & Manish 2005). The immuno-
modulatory potential of Alternanthera maritima extracts 
and isolated flavonoids were recently investigated by 
our research group and it was observed that they have 
stimulatory activity in the humoral immune system 
(Uecker et al. 2003). Alternanthera, a genus belonging 
to the Amaranthaceae family, contains 80 species, 30 of 
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which occur in Brazil (Siqueira & Guimarães 1984). This 
family shows great chemical diversity in its constituents 
(steroids, flavonoids, alkaloids, saponins and terpenes) 
(Patterson et al. 1991, Salvador & Dias 2004), but Am-
aranthaceae is a Brazilian flora component that has not 
been significantly explored. Other species evaluated have 
shown antitumoral (Gomphrena martiana) (Pomilio et al. 
1994), analgesic (Alternanthera brasiliana) (Macedo et al. 
1999) and antiviral (HIV - Alternanthera philoxeroides) 
(Zhang et al. 1988) activities. Alternanthera tenella Col-
la, a herbaceous plant commonly known as “enxuga” or 
“perpétua do mato,” is frequently found in northwest Bra-
zil (Guerra et al. 2003), but also occurs in other regions, 
like the state of São Paulo (Salvador 2005). It is used in 
popular medicine to treat fever, infection and inflamma-
tion (Rego 1995). Other biological activities including an-
tibacterial (Salvador 2005) and antifungal (Salvador et al. 
2003) activity, as well as viability reduction of Trypano-
soma cruzi trypomastigotes and Leishmania amazonensis 
amastigotes (Salvador 2005) have recently been reported. 
Moreover, phytochemical analysis of the antioxidant etha-
nolic extract of A. tenella has also been documented and 
led to the isolation of six major antioxidant flavonoid con-
stituents (Salvador et al. 2006).
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The immunomodulatory and anti-inflammatory ac-
tivities of A. tenella were evaluated in this study based 
upon its utilization in popular medicine and the biologi-
cal activities it has already demonstrated. Plant aqueous 
extracts were evaluated in the context of the BALB/c 
mice immune system by determining its effects on body 
and lymphoid organ weights, splenic cellularity, plaque-
forming cells (PFC), antibody production (ELISA) and 
carrageenan-induced paw edema.
MATERIALS AND METHODS
Plant material and crude extract preparation - Who-
le A. tenella Colla (Amarantaceae) plants were collected 
at Alto da Boa Vista, Ribeirão Preto, São Paulo, Brazil, 
in May 2002, and identified by Professor Dr. JC de Si-
queira (Pontifícia Universidade Católica, Rio de Janeiro, 
RJ). A voucher specimen (register no SPFR 02968) was 
deposited at the herbarium of the Faculdade de Filoso-
fia, Ciências e Letras de Ribeirão Preto, SP, Brazil. The 
fresh material was powdered and cold and hot (50oC) 
distilled water crude lyophilized extracts were prepared 
and identified as CAE and HAE, respectively (Fig. 1). 
The lyophilized extracts were dissolved in pyrogen-
free isotonic saline, sterilized using a Millipore filter 
(0.2 µm) and stored at 4oC.
Phytochemical screening of the aqueous crude ex-
tracts - Phytochemical screening of the extract was car-
ried out using a conventional protocol (Wagner et al. 
1984) for detecting the presence of different constituents 
like tannins, saponins, unsaturated sterols, triterpenoids, 
alkaloids and flavonoids. Common precipitation and col-
oring reagents were used to screen the CAE and HAE for 
phenolic compounds (FeCl3, 2%) and alkaloids (Dragen-
dorff and Mayer reagents). The extracts were monitored 
by TLC chromatography (20 x 20 cm glass plates, 0.25 
mm thick, Si gel GF254, Merck, Brazil), eluted with n-
BuOH/AcOH/H2O (BAW) 65:15:25, and then revealed 
with chromogenic spray reagents (phosphomolybdic acid 
20% in MeOH w/v and p-anisaldehyde 0.5% in H2SO4 
w/v, followed by heating at 110oC and NP/PEG) and ex-
posed to NH3 vapor and UV light at 254 and 366 nm 
(Wagner & Bladt 1996). IR spectra (KBr pellets) were 
recorded using a Nicolet Protégé 460 spectrometer. 1H 
NMR spectra were run with D2O on a Brucker Advance 
DPX 300 (3300 MHz) spectrometer.
Animals - Male BALB/c mice (20-25 g) and adult guin-
ea pigs and adult sheep were used in the study. The Central 
Animal House Facility of Universidade de São Paulo, Ri-
beirão Preto provided all animals. Mice were maintained 
in the Faculdade de Ciências Farmacêuticas de Ribeirão 
Preto, Animal House Facility. Food pellets and water were 
provided ad libitum. All protocols used are in accordance 
with the Guidelines for Ethical Care of Experimental Ani-
mals and approved by the Animal Care and Use Commit-
tee of the Institution (protocol 04.1.474.53.9).
Treatment of mice for PFC and cellularity assays - 
Mice were separated into experimental groups (n = 6). 
Positive control and treated groups were retroorbitally 
immunized with sheep red blood cells (SRBC) (0.1 mL, 
25% suspension in saline) and concomitantly inoculated 
intraperitoneally (i.p.) with 0.2 mL sterile saline (posi-
tive control group) or 0.2 mL of CAE or HAE extracts 
containing 50, 100 or 200 mg/Kg body weight in a single 
administration (treated groups). Negative controls re-
ceived only 0.2 mL sterile saline (i.p.).
Body and lymphoid organ weights - Mouse body 
weights were obtained at the time of immunization (day 
0) and 4, 7 and 14 days after the single treatment with 
extracts. Organ weights for the spleen, liver and thymus 
were determined for each animal after sacrifice by cer-
vical dislocation four or 14 days from start of treatment 
according to the experiment.
Splenic cellularity - Mouse spleens for cell counting 
were prepared in Hank’s balanced salt solution (HBSS). 
Four days after immunization with SRBC and adminis-
tration of different treatments (as described above), the 
spleen was teased apart, the cells treated with 3 mL of 
erythrocyte lysis buffer (0.16 M NH4Cl; 0.17 M Tris; pH 
7.65), washed three times and suspended in HBSS. The 
Neubauer chamber was used for cell counting and viabil-
ity was determined by the Trypan Blue exclusion test.
PFC - Four days after immunization with SRBC 
and different treatments in mice, the PFC assay was 
performed using spleen cells according to the method 
of Jerne and Nordin (1963). Spleen cells collected from 
individual animals (0.1 mL; 1 x 106 cells/0.1 mL), 0.4 mL 
of 0.5% “low melting point” agarose (GIBCO, Grand Is-
land, NY, USA) in HBSS, and 50 µL of a suspension of 
5% SRBC were added to test tubes at 37ºC and poured 
onto microscope slides containing a bottom layer of 0.5% 
agarose in water. The slides were then incubated for 2 h 
at 37ºC and 5% CO2.
 Guinea pig serum diluted 1:4 in 
HBSS was added to the slides and after another 40 min 
(37ºC and 5% CO2) incubation the number of plaques 
was counted and values were expressed as PFC per 106 
cells. For the preparation of guinea pig serum as the 
complement source, animals were anesthetized before 
cardiac puncture and blood samples were collected. Se-
rum was obtained and previously absorbed with SRBC 
before being stored at -70oC. 
Preparation of SRBC membrane antigens - Partially 
purified SRBC membrane antigens were prepared as 
described by Temple et al. (1993) with some modifica-
Fig. 1: a flow chart for the aqueous extraction of lyophilized fresh 
whole plant.
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tions. All procedures were carried out at 4ºC. Briefly, 
sheep blood was collected in Alsever’s solution and cells 
were isolated by centrifugation at 1,000 g for 15 min. 
After removal of plasma and the buffy coat, the cells 
were washed with five volumes of 0.9% NaCl three 
times. The washed pellets were suspended in approxi-
mately two volumes of 0.05 M Tris-HCl with 0.1 mM 
EDTA (pH 7.6), were mixed thoroughly and were centri-
fuged at 25,000 g for 30 min. This process was repeated 
as necessary until the supernatant became clear. The 
pellet suspension was further filtered through three lay-
ers of gauze, centrifuged again and resuspended in 0.1% 
sodium dodecyl sulfate (SDS) with 0.02% sodium azide 
(three times pellet volume). The solubilized membrane 
antigens were dialyzed against 0.1% SDS in PBS (mo-
lecular weight cut-off 12-14 kDa) and stored at -20ºC. 
Total protein quantification was performed as described 
previously using the Bradford (1976) assay.
Enzyme-linked immunosorbent assay (ELISA) - 
Anti-SRBC circulating antibody titers of mice were 
determined by ELISA. SRBC antigen, in aliquots of a 
5 µg/mL suspension in PBS, pH 7.2 (125 µL/well), was 
incubated overnight at 4ºC in high-binding microplates 
(Costar, New York, USA). Prior to each subsequent 
step, plates were washed three times with PBS-T (0.05% 
Tween 20, Sigma-Aldrich, St Louis, MO, in PBS). Un-
bound sites were blocked with 3% powdered milk in 
PBS (200 µL/well) for 2 h at room temperature (RT). 
Serum from experimental animals diluted 1:8 in PBS-T 
was added to the wells (125 µL/well) followed, after 1 h 
incubation at RT, by horseradish peroxidase conju- 
gated anti-mouse IgG (1:1000) and IgM (1:2000) (Caltag 
Laboratories Inc, Burlingame, CA) diluted in PBS-T 
(125 µL/well). After another hour at RT, OPD substrate 
(Sigma FastTM OPD, Sigma-Aldrich, St Louis, MO) was 
added (200 µL/well) and the plates were incubated in 
the dark for 20 min at RT. The reaction was stopped 
with 2 M H2SO4 (75 µL/well) and the color in each well 
was evaluated at 490 nm on an ELISA reader (Spectra-
max Plus, Molecular Devices, Sunnyvale, CA), Soft-
max program.
Carrageenan-induced edema - Mice were treated i.p. 
with 0.2 mL of the aqueous extracts (CAE or HAE), 200 
or 400 mg/kg or indomethacin (5 mg/kg) or sterile sa-
line (control). After 60 min, edema was induced with an 
injection of 50 µL of 1% carrageenan in saline into the 
right hind paw. Paw thicknesses were measured using a 
dial caliper (Mitutoyo, Japan) immediately prior to car-
rageenan injection, 30 min after, and then at hourly in-
tervals up to 5 h afterwards. Data are shown as increases 
in paw thickness and the difference between treated ani-
mals and controls was evaluated at the same time point 
after carrageenan injection. For this assay, mice were 
separated into six groups: (a) controls receiving the ve-
hicle, saline, n = 5; (b) CAE extract (receiving 200 mg/
kg or 400 mg/kg, n = 6); (c) HAE extract (receiving 200 
mg/kg, n = 5 or 400 mg/kg, n = 6); (d) indomethacin 
(receiving 5 mg/kg, n = 6).
Statistical analysis - The results were expressed as 
means  ±  SEM and were evaluated by one-way analysis of 
variance (ANOVA), followed by the Tukey test for multiple 
comparisons of body weights, lymphoid organ weights, 
splenic cellularity evaluation, PFC and ELISA assays. 
Results of the carrageenan-induced edema assay (CIEA) 
were expressed as means ± SD and evaluated by two-way 
ANOVA, followed by the Bonferroni test for multiple 
comparisons. Levels of significance were set at p < 0.05. 
RESULTS
Phytochemical screening - The phytochemical screen-
ing of the aqueous extracts using common precipitation 
and coloring reagents revealed the possible presence of 
flavonoids, tannins, glycosides and saponins. Tests for 
steroids, alkaloids, lactones/ester and protein/amino 
acids were found to be negative. Spectrometric (IR and 
NMR) and chromatographic (TLC) analyses of CAE and 
HAE suggested that flavonoids glycosides and saponins 
are among the main constituents that can be related with 
the biological activity of the extracts. The IR spectrum 
showed absorptions of OH groups (3350 cm-1) and aro-
matic rings (1610, 1515 and 1450 cm-1). The spectrum 
data of 1H-NMR showed the proton resonances com-
monly found on flavonoids and their substituents, such 
as aromatic signals between 6.0-8.0 ppm and anomeric 
protons of sugars between 4.0-5.0 ppm. Moreover, sev-
eral signals attributed to methyl, methylene and olefinic 
groups that suggested the possible presence of saponins 
were observed in the 1H-NMR spectrum (Hostettmann 
et al. 1991, Markham & Geiger 1994). Sesquiterpene lac-
tones were not detected since typical carbonyl bands of 
α,β-unsaturated-γ-lactones were not observed in the IR 
spectrum between 1750-1780 cm-1, while typical olefinic 
protons did not appear in the NMR spectra. The results 
of the phytochemical analysis are shown in Table I. 
The number of positive signs indicated the intensity of 
the reactions that reflect the quantity present.
Effect of CAE and HAE extracts on body and lym-
phoid organ weights - Mice treated once with CAE or 
HAE extracts in doses of 50, 100 or 200 mg/kg did not 
show significant differences in body and lymphoid organ 
weights after 4, 7 and 14 days when compared to controls 
TABLE I
Phytochemical constituents of Alternanthera tenella 
aqueous extracts
Parameters CAE extract HAE extract
Color Brown Brown
Flavonoids ++ +
Tannins ++ +
Saponins +++ +++
Reducing sugars +++ +++
Alkaloids − −
Mucilage − −
Sterols and triterpenoids − −
Lactones/ester − −
+: positive test; −: negative test; +, ++, +++: quantitative 
presence.
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(Tables II, III). Body weights are expressed in absolute 
values and relative organ weights as organ weight (mg)/
body weight (g). Another groups of mice treated i.p. 
with CAE or HAE extracts in doses of 200 or 400 mg/ 
kg (CIEA) also did not demonstrate an organ weight de-
crease (Table IV). However, mice treated with CAE 400 
mg/kg displayed a liver weight increase of 19.5%.
Effect of CAE or HAE extracts on spleen cellularity 
- Spleen cellularity data did not indicate significant in-
creases in treated mice at any of the doses (Fig. 2) when 
compared to the positive control group (animals immu-
nized with SRBC). The positive control groups showed 
an increase in cellularity (p < 0.01 - CAE; p < 0.001 - 
HAE) when compared with negative controls (saline), 
demonstrating immunization efficiency. Cell viability 
was approximately 90%-88% in CAE or HAE-treated 
mice, respectively.
Effect of CAE or HAE extracts in the PFC assay - 
The effect of CAE or HAE extracts on PFC production is 
shown in Fig. 3. Mice treated with CAE 100 mg/kg showed 
a significant increase (p < 0.05) when compared to the 
control groups (Fig. 3A). However, no significant effect 
was seen in animals treated with CAE 50 and 200 mg/ 
kg. Treatment with HAE at all doses did not induce sig-
nificant increases in PFC numbers, but a dose-dependent 
increased tendency in PFC production was observed and 
shown in Fig. 3B.
Effect of CAE or HAE extracts on circulating anti-
body titers - SRBC membrane antigen was prepared as 
described in Material and Methods and contained 0.793 
mg/mL of protein. Anti-SRBC antibody IgM and IgG 
titers were measured in mice serum of different groups, 
collected retroorbitally on 0, 4, 7 and 14 days after im-
munization and treatment. Anti-SRBC IgM and IgG ti-
TABLE II
Effect of Alternanthera tenella cold aqueous extract (CAE) on body and relative organ weights in mice
                                                         Body weight (g)                                          Relative organ weight (mg/g)a
Groups Initial 4 days 7 days 14 days Spleen Thymus Liver
Negative control 22 ± 1 24 ± 1 23 ± 1 24 ± 1 5.1 ± 0.3 2.6 ± 0.3 51.4 ± 1.1
Positive control 22 ± 2 22 ± 1    22 ± 0.5    23 ± 0.4 5.2 ± 0.5 2.8 ± 0.3 50.7 ± 2.8
CAE 50 mg/kg 23 ± 1 23 ± 1 22 ± 1 23 ± 1 8.4 ± 2.1 2.7 ± 0.3 52.8 ± 2.1
CAE 100 mg/kg 22 ± 1 23 ± 1 22 ± 1 23 ± 1 7.6 ± 1.2 2.4 ± 0.3 53.9 ± 2.0
CAE 200 mg/kg 23 ± 1 24 ± 1 23 ± 1 24 ± 1 6.8 ± 1.0 2.8 ± 0.3 53.1 ± 2.3
a: organ weight (mg)/body weight (g) 14 days after treatment; values are means  ±  SEM (n = 6).
TABLE III
Effect of Alternanthera tenella hot aqueous extract (HAE) on body and relative organ weights in mice
                                                                        Body weight (g)                                          Relative organ weight (mg/g)a
Groups Initial 4 days 7 days 14 days Spleen Thymus Liver
Negative control 22 ± 1 23 ± 1 22 ± 1 22 ± 1 4.8 ± 0.3 2.5 ± 0.1 50.5 ± 1.4
Positive control 23 ± 1 24 ± 1 23 ± 1 24 ± 1 7.7 ± 1.9 2.8 ± 0.3 56.4 ± 3.9
HAE 50 mg/kg 23 ± 1 23 ± 1 23 ± 0.2 24 ± 0.2 5.4 ± 0.3 2.7 ± 0.2 50.4 ± 1.9
HAE 100 mg/kg 22 ± 1 22 ± 0.4 22 ± 1 22 ± 1 6.5 ± 1.1 2.5 ± 0.2 50.7 ± 0.8
HAE 200 mg/kg 22 ± 1 22 ± 1 22 ± 1 23 ± 1 7.2 ± 0.9 2.5 ± 0.4 53.7 ± 1.2
a: organ weight (mg)/body weight (g) 14 days after treatment; values are means  ±  SEM (n = 6). 
TABLE IV
Effect of Alternanthera tenella larger doses of cold aqueous extract (CAE) and hot aqueous extract (HAE) on body and relative 
organ weights in mice
                                                                                                                                   Relative organ weight (mg/g)b
Groupsa Body weight (g) Spleen   Thymus  Liver 
Controlc 24.8 ± 1.3 4.3 ± 0.3 2.3 ± 0.3 49.2 ± 0.7
CAE 200 mg/kg 23.7 ± 0.9 4.1 ± 0.0 2.6 ± 0.2 47.2 ± 1.3
CAE 400 mg/kg 24.9 ± 2.0 4.8 ± 0.3 3.2 ± 0.3   58.8 ± 1.3d
HAE 200 mg/kg 22.7 ± 1.1 4.2 ± 0.1 2.2 ± 0.4 45.7 ± 2.1
HAE 400 mg/kg 24.9 ± 1.7 3.9 ± 0.3 2.3 ± 0.2 47.2 ± 0.7
a: mice used in the carrageenan induced paw edema assay; b: organ weight (mg)/body weight (g) 14 days after treatment; values are 
means  ± SEM (n = 5 or 6); c: animals treated with carrageenan and saline; d: p < 0.01 when compared with control group.
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ters increased in immunized and CAE-treated mice as 
shown in Fig. 4. A significant IgM titer increase was 
observed for doses 50, 100 and 200 mg/kg (p < 0.05, 
p < 0.01 and p < 0.01, respectively - Fig. 4B) in compari-
son to the positive control, four days after immunization 
and treatment. The increase was also observed in ani-
mals immunized and treated with 50 mg/kg (p < 0.05) 
compared to positive controls seven days after treatment 
(Fig. 4C). IgG titers also increased significantly in mice 
treated with three doses of CAE 50, 100 and 200 mg/kg 
(p < 0.01, p < 0.05 and p < 0.05, respectively) after seven 
days (Fig. 4C) when compared with immunized-only 
mice (positive control). A similar profile was obtained 
after 14 days, but the differences were not significant 
(Fig. 4D). No significant effect in antibody titers was ob-
served after treatments with HAE extracts in immunized 
animals for any of the doses or periods evaluated (Fig. 5).
Effect of CAE and HAE extracts on carrageenan-in-
duced edema - Fig. 6 shows that injection of carrageenan 
in the control group induced acute inflammation with a 
prominent increase in paw thickness, beginning 1 h after 
intraplantar injection and reaching a peak of inflamma-
tion after 3 and 4 h. i.p. administration of CAE at 200 
or 400 mg/kg, 1 h before the carrageenan injection, in-
duced dose-dependent edema inhibition. CAE 200 mg/
kg, induced 42% inhibition (p < 0.01) after the first hour 
and 50% (p < 0.001) after 3 h. A higher dosage of the ex-
tract (400 mg/kg) inhibited the edema by 61% and 60% 
(p < 0,001) after three and four hours, respectively (Fig. 
6A), an effect that was even higher than that of indo-
methacin (5 mg/kg), the anti-inflammatory drug used in 
the positive control. Indomethacin reduced the edema by 
a maximum of 55% (p < 0.001) after 3 h. HAE extracts at 
a dose of 200 mg/kg, inhibited edema by 40% (p < 0 .01) 
Fig. 2: effect of Alternanthera tenella cold aqueous extract (CAE) (A) 
or hot aqueous extract (HAE) (B) extracts on mice spleen cellularity. 
Data are means ± SEM of six animals. Mice immunized with sheep 
red blood cells (SRBC) were concomitantly treated with CAE or HAE 
in doses of 50 mg/kg, 100 mg/kg or 200 mg/kg. Four days after im-
munization, spleen cells were counted.  *: p < 0.01; **: p < 0.001, when 
compared with negative control group. Negative control: mice treated 
with sterile saline; positive control: mice immunized with SRBC and 
treated with sterile saline.
Fig. 3: effect of Alternanthera tenella cold aqueous extract (CAE) (A) 
or hot aqueous extract (HAE) (B) extracts plake-forming cell num-
bers (PFC). Data are means ± SEM of six animals. Mice immunized 
with sheep red blood cells (SRBC) were concomitantly treated with 
CAE or HAE in doses of 50 mg/kg, 100 mg/kg or 200 mg/kg. Four 
days after immunization, PFC was enumerated in spleen cells. *: p < 
0.01, when compared with negative control group; **: p < 0.05 when 
compared to positive control group. Negative control: mice treated 
with sterile saline; positive control: mice immunized with SRBC and 
treated with sterile saline.
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only at the first hour. More effectively, HAE 400 mg/kg 
inhibited edema 2 h after carrageenan administration, 
reaching a maximum of 56% (p < 0.001) at 3 h (Fig. 6B).
DISCUSSION
The therapeutic potential of several plant species and 
the necessity for scientific validation of the use of plants 
in popular medicine have prompted increased interest 
in the field. A large number of plant species and their 
components have been shown to be potential immuno-
modulators acting as anti-inflammatory, antistress and 
anticancer agents (Bin-Hafeez et al. 2003). In this study, 
we investigated the immunomodulatory/immunotoxic 
and anti-inflammatory effects of aqueous extracts of 
A. tenella obtained in different conditions. The results 
suggest that A. tenella contains immunomodulators, in 
accordance with previous studies (Moraes et al. 1994, 
Silveira 2000, Guerra et al. 2003).
After four and 14 days of i.p. administration, extracts 
CAE and HAE did not alter spleen weights in mice at the 
concentrations evaluated. A decrease in spleen weight 
Fig. 4: effect of Alternanthera tenella cold aqueous extract (CAE) on anti-sheep red blood cells (SRBC) antibody IgM and IgG titers on days 0 
(A), 4 (B), 7 (C) and 14 (D) after mice immunization. Data are means ± SEM of four to six animals. Mice immunized with SRBC and treated with 
CAE in doses: 50 mg/kg, 100 mg/kg or 200 mg/kg; * : p < 0.05, when compared with positive control group; **: p < 0.01, when compared with posi-
tive control group. Negative control: mice treated with sterile saline; positive control: mice immunized with SRBC and treated with sterile saline.
would be indicative of immunotoxicity (Doi et al. 1996). 
Other organs like the liver and thymus, also involved in 
toxic conditions, did not show significant differences 
in weight in comparison to controls when the animals 
were treated by doses of 50, 100 and 200 mg/kg of both 
extracts. However, the increase in liver weight in mice 
treated with CAE 400 mg/kg could be attributed to a 
toxic effect. Liver enlargement occurs in animals and 
humans as a result of physiological adaptation, metabol-
ic abnormalities, toxic effects, inflammatory processes 
or proliferative diseases (Williams & Iatropoulos 2002). 
However, we could not positively identify a relevant 
toxic effect from this result since histopathological ex-
amination and/or biochemical measurements were not 
performed in this study.
The PFC assay is considered to be one of the most high-
ly predictive single assays for detection of the immuno-
modulatory/immunotoxic potential of several substances 
and drugs. It was used to assess potential modulation of 
the humoral immune response, which quantifies the num-
ber of B cells producing SRBC-specific IgM (Wilson et 
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Fig. 5: effect of Alternanthera tenella hot aqueous extract (HAE) on anti-sheep red blood cells (SRBC) antibody IgM and IgG titers on days 0 
(A), 4 (B), 7 (C) and 14 (D) after mice immunization. Data are means ± SEM of four to six animals. Mice immunized with SRBC and treated 
with HAE in doses of: 50 mg/kg, 100 mg/kg or 200 mg/kg. Negative control: mice treated with sterile saline; positive control: mice immunized 
with SRBC and treated with sterile saline.
al. 1999). It is considered that substances and preparations 
inducing PFC increases are immunostimulators (Davis & 
Kuttan 2000). The increased number of PFCs in animals 
treated with 100 mg/kg of CAE (p < 0.05) therefore sug-
gests the presence of immunomodulators. Previous stud-
ies in our laboratory showed similar results for A. mariti-
ma (M Uecker, unpublished observations). HAE or CAE 
water root extracts of the plant in 100 mg/kg doses were 
able to induce an increase in PFCs.
In this study, the increased anti-SRBC IgM titers 
four days after treatment with the three doses of CAE 
(p < 0.05, p < 0.01, p < 0.01, respectively) and after seven 
days with the lower dosage, in addition to increased IgG 
titers after seven days treatment, reinforces the hypoth-
esis concerning immunomodulatory extract properties. 
In contrast with our results, Guerra et al. (2003), us-
ing the same method employed in the present study (an-
ti-SRBC IgM-producing cells/PFC), demonstrated that 
the aqueous extract of A. tenella (5 mg/kg) caused a sig-
nificant reduction of anti-SRBC IgM-specific cells. At a 
higher dose (50 mg/kg), the same extract had no effect 
on IgM specific response. According to these authors, 
this immunosupressive activity of inhibiting produc-
tion of antibodies to T-dependent antigens could be con-
comitant with immunostimulant properties increasing 
production of mitogen-induced antibodies. The present 
study demonstrated that 100 mg/kg of CAE, adminis-
tered concomitantly with the immunization with SRBC, 
increased the number of anti-SRBC PFCs. Doses of 50 
and 200 mg/kg showed no differences in PFC numbers 
(Fig. 3A). However, anti-SRBC IgM and IgG serum ti-
ters as measured by ELISA were significantly enhanced 
after administration of the three doses of CAE (50, 100 
and 200 mg/kg) four and seven days after immunization 
with SRBC, respectively (Figs 4A, B). We can speculate 
that these differences between our results and those of 
Guerra et al. (2003) may be due to variations in mouse 
strain (Swiss vs. BALB/c), route of antigen administra-
tion (i.p. vs i.v.), scheme/timing of extract administration 
(previous vs concomitant to immunization) and sensitiv-
ity of antibody detection methods (PFC vs ELISA). In ad-
dition, such differences may be attributed to variation in 
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the chemical composition of plants according to the geo-
graphical area and the time or season of collection. Dif-
ferences in the plant parts used and extract preparation 
process may also explain the discrepancy in the results. 
The carrageenan-induced paw edema assay, con-
ducted to evaluate anti-inflammatory activity (Winter et 
al. 1962) in A. tenella extracts, is a frequently used and 
adequate model used since 1962 in rodents, and is be-
lieved to be biphasic. The first phase involves serotonin, 
histamine and kinin release followed by a second phase, 
which is mediated by prostaglandin and cyclooxygenase 
products (Vinegar et al. 1969).  In the present study, the 
paw edema was significantly reduced by 200 or 400 mg/
kg of CAE extract (p < 0.001) and 400 mg/kg of HAE 
(p < 0.001). The pattern of anti-inflammatory activity ex-
hibited by A. tenella extracts, which is similar to that of 
indomethacin used as positive control in this study, tend 
to suggest that the plant activity may at least be partially 
mediated by cyclooxygenase -1 and -2 inhibition. Moraes 
et al. (1994) suggest that the blockade of lymphocyte pro-
liferation by a component isolated from A. tenella may 
contribute to the plant anti-inflammatory properties since 
stimulated lymphocytes secret cytokines which attract 
neutrophils during the inflammatory process. The results 
of the paw edema assay prompt the hypothesis that CAE 
has components with immunosupressive activity along-
side others, which could be immunostimulatory since 
stimulation of PFC was demonstrated. Several other plant 
extracts have also been shown to have simultaneous im-
munosupressive and immunostimulatory effects (Yama-
guchi 1992, Mediratta et al. 2002).
The aqueous extracts of A. tenella were obtained by 
maceration with the same proportion of the powdered 
fresh plant and solvent mass (1:20 mpl/msol) at RT 
(27oC) and at 50oC, with time of extraction being 12 h and 
30 min for CAE and HAE extraction, respectively 
(Fig. 1). The different time in extraction can lead to dif- 
ferent contents for the active compounds in the lyo-
philized aqueous extracts prepared. In addition, the CAE 
extract yield was 9.80 g, while the HAE yield was 4.14 
g from the same mass of powdered fresh plant (250 g). 
The cold water can lead to the extraction of distinct com-
pounds with the same class of secondary metabolites in 
comparison with hot water or at different concentrations, 
in spite of the increase in temperature. These facts, at 
least partly, can justify the difference in the biological 
activity observed for the extracts CAE and HAE. The 
difference between the extract effects could be also due 
to the presence of constituents not extracted or destroyed 
depending on the extraction process.
The initial chemical characterization of the A. tenel-
la aqueous extracts has demonstrated the occurrence of 
flavonoids, tannins, glycosides and saponins. Flavonoid 
heterosides, like quercetin, isorhamnetin and kaempf-
erol, could be present as aglycone. These flavonoids 
were previously isolated in the phytochemical studies 
performed with the ethanol extracts of this plant (Salva-
dor et al. 2006). Flavonoids have many pharmacologic 
properties including immunomodulatory, anti-oxidant 
and anti-inflammatory activities (Ielpo et al. 2000) and 
its presence in the extracts could explain, at least par-
tially, the results obtained in this work. 
As a whole, our results contribute to a comprehen-
sive understanding of the plant’s biological properties 
and provide a scientific foundation for its popular use. 
ACKNOWLEDGEMENTS
To Professor Dr. JC de Siqueira, for the botanical identi-
fication of plant material, Dra. Glória Emilia Petto de Souza, 
for her helpful suggestions and discussions during the course 
of this work, Ms. Ana Cristina Morseli Polizello, for helping 
in the blood samplings of the guinea pigs, Ms. Ana Elisa CS 
Fig. 6: effect of Alternanthera tenella cold aqueous extract (CAE) (A) 
or hot aqueous extract (HAE) (B) on carrageenan induced paw edema 
in mice. Data are means ± SD. Mice treated with CAE 200 mg/kg 
(n = 6) and CAE 400 mg/kg (n = 6). Mice treated with HAE 200 mg/kg 
(n = 5) and HAE 400 mg/kg (n = 6); *: p < 0.05; **: p < 0.01; ***: p < 0.001 
when compared with control group. Control: mice treated with 
sterile saline (n = 5); indomethacin: mice treated with indometh-
acin 5 mg/kg (n = 6).
577Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 103(6), September 2008
Azzolini, for her help in the preparation of SRBC membrane 
antigen, and Tânia Mara Casare Ogasawara and Rubens Edu-
ardo da Silva, for skillful technical assistance.
REFERENCES
Barnes J, Anderson LA, Gibbons S, Phillipson JD 2005. Echinacea 
species (Echinacea angustifolia (DC.) Hell., Echinacea pallida 
(Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their 
chemistry, pharmacology and clinical properties. J Pharm Phar-
macol 57: 929-954.
Bin-Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I, Raisuddin S 
2003. Immunomodulatory effects of fenugreek (Trigonella foenum 
graecum L.) extract in mice. Int Immunopharmacol 3: 257-265.
Bradford MM 1976. A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the principle of 
protein-dye binding. Anal Biochem 72: 248-254.
Cheng W, Li J, You T, Hu C 2005. Anti-inflammatory and immuno-
modulatory activities of the extracts from the inflorescence of 
Chrysanthemum indicum Linné. J Ethnopharmacol 101: 334-337.
Davis L, Kuttan G 2000. Immunomodulatory activity of Withania 
somnifera. J Ethnopharmacol 71: 193-200.
De Pasquale A 1984. Pharmacognosy: the oldest modern science. 
J Ethnopharmacol 1: 1-16.
Doi T, Nagai H, Tsukuda R, Suzuki T 1996. Dose-response relation-
ships, PFC response and histology in the spleen in rats treated 
with alkylating agents. Toxicology 107: 47-60.
Guerra RNM, Pereira H-AW, Silveira LMS, Olea RSG 2003. Immu-
nomodulatory properties of Alternanthera tenella Colla aqueous 
extracts in mice. Braz J Med Biol Res 36: 1215-1219.
Hostettmann K, Hostettmann M, Marston A 1991. Saponins. In PM 
Dey, JB Harbome Methods in plants biochemistry, Vol. 7, Spring-
er, Berlin, p. 435-471.
Ielpo MTL, Basile A, Miranda R, Moscatiello V, Nappo C, Sorbo 
S, Laghi E, Ricciardi MM, Ricciardi L, Vuotto ML 2000. Im-
munopharmacological properties of flavonoids. Fitoterapia 71 
(Suppl.): S101-S109.
Jerne NK, Nordin AA 1963. Plaque formation in agar by single anti-
body producing cells. Science 140: 405.
Macedo AF, Barbosa NC, Esquibel MA, Souza MN, Cechinel-Filho V 
1999. Pharmacological and phytochemical studies of callus culture 
extracts from Alternanthera brasiliana. Pharmazie 54: 776-777.
Markham KR, Geiger H 1994. 1H nuclear magnetic resonance spec-
troscopy of flavonoids and their glycosides in hexadeuterodime-
tylsulfoxide. In JB Harbone, The flavonoids, Chapman and Hall, 
London, p. 450-453.
Mediratta PK, Sharma KK, Singh S 2002. Evaluation of immuno-
modulatory potential of Ocimum sanctum seed oil and its pos-
sible mechanism of action. J Ethnopharmacol 80: 15-20.
Moraes VJG, Santos LFM, Castro SB, Loureiro LH, Lima OA, Souza 
MLM, Yien LMK, Rossi-Bergmann B, Costa SS 1994. Inhibition 
of lymphocyte activation by extracts and fractions of Kalanchoe, 
Alternanthera, Paullinia and Mikania species. Phytomedicine 1: 
199-204.
Patterson WG, Xu S, Salt TA 1991. Sterol of Caryophyllales with em-
phasis on Amaranthaceae. Phytochemistry 30: 523-526.
Patwardhan B, Manish G 2005. Botanical immunodrugs: scope and 
opportunities. Drug Discov Today 10: 495-502.
Pomilio AB, Solá GAR, Mayer AMS 1994. Antitumor and cytotoxic 
screen of 5,6,7-trisubstituted flavones from Gomphrena mar-
tiana. J Ethnopharmacol 44: 25-33.
Rego TJA 1995. Fitogeografia das Plantas Medicinais no Maranhão, 
2nd ed., EDUFMA, São Luís, 133 pp.
Salvador MJ 2005. Estudo químico, biológico e biotecnológico de 
Alternanthera maritima e Alternanthera tenella (Gomphreneae, 
Amaranthaceae). PhD Thesis, Faculdade de Filosofia, Ciências 
e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão 
Preto, São Paulo, 407 pp.
Salvador MJ, Dias DA 2004. Flavone C-glycosides from Alternan-
thera maritima (Mart) St. Hill. (Amaranthaceae). Biochem Syst 
Ecol 32: 107-110.
Salvador MJ, Ferreira EO, Mertens-Talcott SU, Castro WV, Butter-
weck V, Derendorf H, Dias DA 2006. Isolation and HPLC quan-
titative analysis of antioxidant flavonoids from Alternanthera 
tenella Colla. Z  Naturforsch 61: 19-25.
Salvador MJ, Ferreira JC, Zuleta LMC, Bolzani VS, Dias DA, Can-
dido RC 2003. Antifungal susceptibility tests of crude extracts 
from Alternanthera maritima, A. tenella Colla and Calycophyl-
lum spruceanum Benth against four Candida ssp determined by 
agar-well diffusion and Broth macrodilution methods. Braz J 
Pharm Sci 39: 240.
Silveira LMS 2000. Caracterização fitoquímica, biológica e min-
eral de partes aéreas de Alternanthera tenella Colla (Amaran-
thaceae). Msc Thesis, Universidade Federal do Maranhão, São 
Luís, Maranhão, 134 pp.
Siqueira JC, Guimarães EF 1984. Amaranthaceae no Rio de Janeiro – 
gênero Alternanthera forsskal. Rodriguésia 36: 21-40.
Temple L, Kawabata TT, Munson AE, White Jr KL 1993. Compari-
son of ELISA and plaque-forming cells assays for measuring the 
humoral immune response to SRBC in rats and mice treated with 
benzo[a]pyrene or cyclophosphamide. Fundam Appl Toxicol 21: 
412-419.
Uecker M, Biella CA, Salvador MJ, Ogasawara TMC, Dias DA, Perei-
ra-Crott LSP 2003. Screening of Alternanthera maritima extracts 
for immunomodulatory activity. Braz J Pharm Sci 39: 249.
Vinegar R, Schreiber W, Hugo R 1969. Biphasic development of car-
rageenan oedema in rats. J Pharmacol Exp Ther 166: 96-103.
Wagner H, Bladt S 1996. Plant drug analysis: a thin-layer chroma-
tography atlas, 2nd ed., Springer, Berlin, 384 pp.
Wagner H, Bladt S, Zgainski EM 1984. Plant drug analysis, Springer-
Verlag, New York, xiii + 320 pp.
Williams GM, Iatropoulos MJ 2002. Alteration of liver cell function 
and proliferation: differentiation between adaptation and toxicity. 
Toxicol Pathol 30: 41-53. 
Wilson SD, Munson AE, Meade BJ 1999. Assessment of the func-
tional integrity of the humoral immune response: the plaque-
forming cell assay and the enzyme-linked immunosorbent as-
say. Methods 19: 3-7.
Winter CA, Risley EA, Nuss GW 1962. Carrageenan-induced edema 
in hind paw of the rat as an assay for anti-inflammatory drugs. 
Proc Soc Exp Biol Med 111: 544-547.
Yamaguchi H 1992. Immunomodulation by medicinal plants. Adv 
Exp Med Biol 319: 287-297.
Zhang SM, He YS, Tabba JD, Smith KM 1988. Inhibitor against the 
human immunodeficiency virus in aqueous extract of Alternan-
thera philoxeroides. Chin Med J 101: 861-866.
